1. Clinical effects and gut microbiota changes of using probiotics, prebiotics or synbiotics in inflammatory bowel disease: a systematic review and meta-analysis
   Xiao-Feng Zhang et al, 2021, European Journal of Nutrition CrossRef
2. Jowiseungki decoction affects diabetic nephropathy in mice through renal injury inhibition as evidenced by network pharmacology and gut microbiota analyses
   Xianglong Meng et al, 2020, Chinese Medicine CrossRef
3. Prebiotics, Probiotics, Synbiotics, Paraprobiotics and Postbiotic Compounds in IBD
   Adrian Martyniak et al, 2021, Biomolecules CrossRef
4. Probiotics as a Coadjuvant Factor in Active or Quiescent Inflammatory Bowel Disease of Adults—A Meta-Analytical Study
   Manuel Pabón-Carrasco et al, 2020, Nutrients CrossRef
5. Efficiency of Treatment Targeted on Gut Microbiota in Inflammatory Bowel Diseases: Current Strategies and Perspectives
   Daniela Cornelia Lazar et al, 2023, Benign Anorectal Disorders - An Update CrossRef
6. Reviewing the potential of probiotics, prebiotics and synbiotics: advancements in treatment of ulcerative colitis
   Apurva Jadhav et al, 2023, Frontiers in Cellular and Infection Microbiology CrossRef
7. Intestinal microecology-based treatment for inflammatory bowel disease: Progress and prospects
   Xia-Xiao Yan et al, 2023, World Journal of Clinical Cases CrossRef